{
    "clinical_study": {
        "@rank": "6640", 
        "acronym": "9055A1-2000", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Other", 
                "description": "Standard infant formula"
            }, 
            {
                "arm_group_label": "Experimental 1", 
                "arm_group_type": "Experimental", 
                "description": "Standard infant formula containing a new fat blend"
            }, 
            {
                "arm_group_label": "Experimental  2", 
                "arm_group_type": "Experimental", 
                "description": "Standard infant formula containing a new fat blend and fiber"
            }, 
            {
                "arm_group_label": "Human Milk (HM)", 
                "arm_group_type": "No Intervention", 
                "description": "Non-randomized Human Milk group"
            }
        ], 
        "brief_summary": {
            "textblock": "-  The primary objective of the study was to compare stool composition (stool soap and\n           non-soap fatty acids, total fatty acids, minerals, and other stool constituents) of\n           infants randomized to receive either standard formula, or 1 of 2 innovative formulas\n           containing a new fat blend or the new fat blend plus fiber.\n\n        -  The secondary objectives were to evaluate among the feeding groups, stool\n           characteristics (stool consistency and frequency), GI tolerance assessed by the Infant\n           Gastrointestinal Symptom Questionnaire (IGSQ), and urinary markers (F2-isoprostanes and\n           8-hydroxy-2'-deoxyguanosine [8-OHdG], and urine osmolality and specific gravity).\n\n        -  The primary safety objective was to describe the frequency of adverse events (AEs)\n           among the formula-fed (FF) groups.\n\n        -  The secondary safety objective was to describe anthropometric measures (weight, length,\n           and head circumference) among the feeding groups."
        }, 
        "brief_title": "Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Bottle Feeding", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy, term (no less than 37 weeks and no greater than 42 weeks) singleton infants;\n             between 25 days to 45 days post natal age (date of birth = Day 0) and weight for age\n             \u22653rd and \u226497th percentiles according to Taiwan growth charts at the time of study\n             entry.\n\n          -  Human milk fed infants were exclusively consuming and tolerating HM and the mother\n             must have made the decision to continue to exclusively breastfeed.\n\n          -  Formula-fed infants were exclusively consuming and tolerating a cow's milk infant\n             formula and parents/LAR must have previously made the decision to continue to\n             exclusively formula feed.\n\n        Exclusion Criteria:\n\n          -  Infants receiving any amount of supplemental HM with infant formula feeding or vice\n             versa\n\n          -  Family history of siblings with documented cow's milk protein intolerance/allergy\n\n          -  Major congenital malformations, suspected or documented systemic or congenital\n             infections, evidence systemic diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031003", 
            "org_study_id": "B3611001"
        }, 
        "intervention": {
            "arm_group_label": [
                "Control", 
                "Experimental 1", 
                "Experimental  2"
            ], 
            "description": "Infant formula", 
            "intervention_name": "Infant formula", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 7, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Linkuo", 
                        "country": "Taiwan", 
                        "state": "Tao-Yuan County"
                    }, 
                    "name": "Chang Gung Medical Foundation - LinKuo Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hsinchu", 
                        "country": "Taiwan"
                    }, 
                    "name": "Mackay Memorial Hospital - Hsinchu Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan"
                    }, 
                    "name": "Chang Gung Medical Foundation, Taipei Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei City", 
                        "country": "Taiwan"
                    }, 
                    "name": "Mackay Memorial Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of an Infant Formula With High 2-Palmitic Vegetable Oil or an Identical Formula Supplemented With Oligofructose on Stool Composition and Stool Characteristics in Healthy Term Infants in Taiwan", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents", 
            "measure": "Stool Composition", 
            "safety_issue": "No", 
            "time_frame": "Day 28"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031003"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Stool consistency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits.  Average stool consistency scores are recorded on a validated 5-point scale (1 = Watery, 2 = Runny, 3 = Mushy Soft, 4 = Formed, 5 = Hard).", 
                "measure": "Stool Consistency determined using a 3-day stool diary", 
                "safety_issue": "No", 
                "time_frame": "Days 14 and 28"
            }, 
            {
                "description": "Stool frequency data is collected using a 3-day stool diary completed by parents just prior to the Day 14 and Day 28 clinic visits.  The average number of stools per day is determined for each consecutive 3-day period.", 
                "measure": "Stool frequency determined using a 3-day stool diary", 
                "safety_issue": "No", 
                "time_frame": "Day 14 and 28"
            }, 
            {
                "description": "GI tolerance assessed by the Infant Gastrointestinal Symptom Questionnaire (IGSQ)", 
                "measure": "GI Tolerance", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Day 14 and Day 28"
            }, 
            {
                "measure": "Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "From ICF signing until 14 days after last study feeding"
            }, 
            {
                "description": "Observed anthropometry measurements and derived z-scores will be determined and summarized by feeding group and by study visit.", 
                "measure": "Anthropometric measurements (weight, length and head circumference)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, Day 14 and Day 28"
            }, 
            {
                "description": "Measure of hydration status", 
                "measure": "Urine osmolality", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and Day 28"
            }, 
            {
                "description": "Measure of hydration status", 
                "measure": "Urine pH", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and Day 28"
            }
        ], 
        "source": "Nestl\u00e9", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nestl\u00e9", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}